Jurkat nuclear extract (TPA + CI stimulated)
-
- Lysatspezies
- Human Cells
- Produktmerkmale
-
Origin: Human T lymphoblast, acute T cell leukemia
- Bestandteile
- 2 x 100 μg of Jurkat nuclear extract (TPA + CI stimulated) at 2.5 μg/μl
- Lysed Cells
- Jurkat Cells
- Lysate Type
- Cell Lysate
- Lysate Fraction
- Nuclear Extract
- Lysate Treatment
- TPA + CI stimulated
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 2.5 μg/μL
- Buffer
- Nuclear extracts are supplied in dilution buffer (20 mM Hepes ( pH 7.9), 100 mM KCl, 1 mM MgCl2, 20 % glycerol, 0.5 mM PMSF and 0.5 mM DTT). Cells were cultured in medium supplemented with 50 ng/mL TPA (phorbol, 12-myristate, 13 acetate) and 0.5 μM calcium ionophore A23187 (CI) for two hours at 37 °C immediately prior to harvesting.
- Konservierungsmittel
- Dithiothreitol (DTT)
- Vorsichtsmaßnahmen
- This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- It ist recommended to aliquot the extracts into single-use fractions and then storing them at -80 °C. This eliminates repeated freeze/thaw cycles.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- To ensure stability, extracts should be stored at -80°C.
-